October 11, 2021 Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer’s Disease read article
September 20, 2021 Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories read article
September 13, 2021 Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test read article